Tudorza Pressair

Chemical Nameaclidinium bromide
Dosage FormPowder (inhalation; 400mcg)
Drug ClassAnticholinergics
SystemRespiratory
CompanyAlmirall
Approval Year2012

Indication

  • For the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Last updated on 12/16/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Tudorza Pressair (aclidinium bromide) Prescribing Information2019Circassia Pharmaceuticals Inc., Morrisville, NC